We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Capsulution NanoScience Starts New Feasibility Studies
News

Capsulution NanoScience Starts New Feasibility Studies

The studies aim at increasing the bioavailability of several new chemical entities in the human body.
DNT Signs Collaboration Agreement with NCL
News

DNT Signs Collaboration Agreement with NCL

NCL will characterize DNT's STARBURST™ dendrimers as macromolecular dendrimer-based MRI contrast agents.
Inpharmatica Licenses Admensa Interactive™ to Mochida
News

Inpharmatica Licenses Admensa Interactive™ to Mochida

Under the terms of this agreement, Mochida will receive a multi-user license to Admensa Interactive.
Power3 Medical's CSO to Address OncoProteomics World Congress;
News

Power3 Medical's CSO to Address OncoProteomics World Congress;

Goldknopf to Present Results on Breast Cancer and Leukemia and to Join Conference Scientific Advisory Board.
Galapagos Obtains U.S. Patent Protecting Its Discovery Platform
News

Galapagos Obtains U.S. Patent Protecting Its Discovery Platform

This patent protects the method of determining the function of a nucleic acid.
Diosynth Announces Agreement with ImmunoGen
News

Diosynth Announces Agreement with ImmunoGen

Diosynth will manufacture bulk huN901 antibody for ImmunoGen.
Kreido’s STT® Reactor System to Be Utilized by Huntsman
News

Kreido’s STT® Reactor System to Be Utilized by Huntsman

The STT® system improves selectivity, increase yields and initiate chemistries.
Rib-X Granted Key Antibiotic Drug Discovery Patents
News

Rib-X Granted Key Antibiotic Drug Discovery Patents

The patents describe Rib-X's position on crystal structures of the 50S subunit of the ribosome.
Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes
News

Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes

The goal of the Global Initiative is to accelerate the scientific and medical discoveries.
Aureus Licenses AurSCOPE® GPCR to Euroscreen
News

Aureus Licenses AurSCOPE® GPCR to Euroscreen

Euroscreen will use Aureus Pharma's technology to identify GPCR drug candidates.
Advertisement